These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9831970)

  • 1. Aminoglycoside pharmacokinetics in African-Americans with normal renal function.
    Oparaoji EC; Siram S; Elemihe U; Mezghebe HM; Cho T; Bashiri M; Piedrahita K; Pipalla RS
    J Clin Pharm Ther; 1998 Jun; 23(3):191-7. PubMed ID: 9831970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
    Cropp CD; Davis GA; Ensom MH
    Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside pharmacokinetic parameters in neurocritical care patients undergoing induced hypothermia.
    Mercer JM; Neyens RR
    Pharmacotherapy; 2010 Jul; 30(7):654-60. PubMed ID: 20575630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
    Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
    Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removing race and body surface area indexation for estimated kidney function based drug dosing: Aminoglycosides as justification of these principles.
    Pai MP; Sitaruno S; Abdelnabi M
    Pharmacotherapy; 2023 Jan; 43(1):35-42. PubMed ID: 36401789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients.
    Zarowitz BJ; Robert S; Peterson EL
    Ann Pharmacother; 1992 Oct; 26(10):1205-10. PubMed ID: 1421639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
    Matthews I; Kirkpatrick C; Holford N
    Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four once-daily aminoglycoside dosing nomograms.
    Wallace AW; Jones M; Bertino JS
    Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside monitoring program.
    Vakoutis J; Stein GE; Miller PB; Clayman AE
    Am J Hosp Pharm; 1981 Oct; 38(10):1477-80. PubMed ID: 7294041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients.
    Fuhs DW; Mann HJ; Kubajak CA; Cerra FB
    Clin Pharm; 1988 Mar; 7(3):207-13. PubMed ID: 3356116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.
    King CH; Creger RJ; Ellner JJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):285-90. PubMed ID: 3994344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.